Negative Charge-Carrying Glycans Attached to Exosomes as Novel Liquid Biopsy Marker
Authors:
- Natalia KosutovaNKNatalia Kosutova
- Lenka LorencovaLLLenka Lorencova
- Michal HiresMHMichal Hires
- Eduard JaneEJEduard Jane
- Lubomir OrovcikLOLubomir Orovcik
- Jozef KollarJKJozef Kollar
- Katarina KozicsKKKatarina Kozics
- Alena GabelovaAGAlena Gabelova
- Egor UkraintsevEUEgor Ukraintsev
- Bohuslav RezekBRBohuslav Rezek
- Peter KasakPeter Kasak
- Hana CernockaHCHana Cernocka
Open Access
Abstract
Prostate cancer (PCa) is the second most common cancer. In this paper, the isolation and properties of exosomes as potential novel liquid biopsy markers for early PCa liquid biopsy diagnosis are investigated using two prostate human cell lines, i.e., benign (control) cell line RWPE1 and carcinoma cell line 22Rv1. Exosomes produced by both cell lines are characterised by various methods including nanoparticle-tracking analysis, dynamic light scattering, scanning electron microscopy and atomic force microscopy. In addition, surface plasmon resonance (SPR) is used to study three different receptors on the exosomal surface (CD63, CD81 and prostate-specific membrane antigen-PMSA), implementing monoclonal antibodies and identifying the type of glycans present on the surface of exosomes using lectins (glycan-recognising proteins). Electrochemical analysis is used to understand the interfacial properties of exosomes. The results indicate that cancerous exosomes are smaller, are produced at higher concentrations, and exhibit more nega tive zeta potential than the control exosomes. The SPR experiments confirm that negatively charged α-2,3- and α-2,6-sialic acid-containing glycans are found in greater abundance on carcinoma exosomes, whereas bisecting and branched glycans are more abundant in the control exosomes. The SPR results also show that a sandwich antibody/exosomes/lectins configuration could be constructed for effective glycoprofiling of exosomes as a novel liquid biopsy marker.Keywords
Funding Information
- Slovak Research and Development Agency (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
- Slovak Grant Agency VEGA (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
- Qatar University and Institute of Chemistry, Slovak Academy of Sciences (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
- V4-Korea 2023 Joint Call and Czech Science Foundation (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
- TACOM (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
- SenDiSo (APVV-21-0329, APVV-22-0345, 2/0164/24, IRCC-2024-429, 22-26590, TM03000033, CZ.02.01.01/00/22_008/0004596)
This publication has 65 references indexed in Scilit:
- Orthogonal Surface‐Enhanced Raman Scattering/Field‐Effect Transistor Detection of Breast and Colorectal Cancer‐Derived Exosomes using Graphene as a Tag‐Free Diagnostic TemplateAdvanced NanoBiomed Research, 2023
- Nanomaterials-Based Exosomes for the Diagnostics and Drug Deliveries of Central Nervous System DiseasesBioChip Journal, 2023
- Recent developments in biosensing methods for extracellular vesicle protein characterizationWIREs Nanomedicine and Nanobiotechnology, 2022
- Identification of storage conditions stabilizing extracellular vesicles preparationsJournal of Extracellular Vesicles, 2022
- Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoformsGlycoconjugate Journal, 2020
- Exosomes as a Source of Cancer Biomarkers: Advances in Electrochemical Biosensing of ExosomesChemElectroChem, 2020
- Isolation and Analysis of Tumor‐Derived ExosomesCurrent Protocols in Immunology, 2019
- Exosomes play roles in sequential processes of tumor metastasisInternational Journal of Cancer, 2018
- Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseasesPediatric Nephrology, 2017
- Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities – a radiologist's perspectiveNMR in Biomedicine, 2013